Scientists have developed liquid-metal ‘nano-terminators’ to target cancer cells

Pinterest LinkedIn Tumblr +

nanotechnology terminator concept_oncology news australiaBy Peter Dockrill – Science Alert.

Liquid-metal terminators are generally something to be afraid of – but what if the substance was used to fight cancer instead of wiping out humanity?

That’s exactly what researchers in the US are working on, having developed a biodegradable liquid metal that can be used as a drug delivery technique to target cancer cells.

“The advance here is that we have a drug-delivery technique that may enhance the effectiveness of the drugs being delivered, can help doctors locate tumours, can be produced in bulk, and appears to be wholly biodegradable with very low toxicity,” said Zhen Gu, a biomedical engineer in a joint program at North Carolina’s State University and University at Chapel Hill.

“And one of the advantages of this technique is that these liquid metal drug carriers – or ‘nano-terminators’ – are very easy to make.”

To make the nano-terminators, the researchers deposit liquid metal (a gallium indium alloy) into a solution with molecules called polymeric ligands. Bombarding the solution with ultrasound waves causes the liquid metal to burst into nanoscale droplets measuring about 100 nanometres in diameter. The ligands attach to the surface of the droplets and form a skin that prevents the alloy from fusing back together T–1000-style.

sound waves concept_oncology news australiaWhen the anti-cancer drug doxorubicin is introduced to the solution, the ligands on the nanodroplet absorb it, creating drug-laden vessels that can be separated from the solution and introduced into the bloodstream.

But that’s not all. An additional type of ligand that attaches to the nanodroplets can effectively seek out and target cancer cells, by making receptors on the surface of the cells latch onto and ultimately absorb the nanodroplets – which ends up releasing the doxorubicin inside the cancer cell. Hasta la vista.

When inside the cancer cell, the liquid metal reacts with the cell’s acidity and releases gallium ions, which actually boosts the performance of the doxorubicin while simultaneously degrading the metal…read the full story.


About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Comments are closed.